• The Money Question: Cost-Effectiveness in Drug Discovery

    Apr 3, 2012, 02:20 AM by Michael Croft
    Xconomy | Cost-effectiveness in biotech and drug discovery can no longer be a secondary consideration, but the cost of drugs to patients is still not frequently discussed. 
    Full story

  • Oracle Acquires ClearTrials Clinical Trials Software

    Apr 2, 2012, 04:00 AM by Michael Croft
    PC World | Oracle acquired ClearTrial late last week for an undisclosed amount in a deal expected to close in the first half of the year. Oracle hopes to combine ClearTrial's cloud-based clinical trials software offerings with its existing portfolio including tools.
    Full story

  • DIY Clinical Trials

    Apr 2, 2012, 04:00 AM by Michael Croft
    WSJ Blog | DIY science is growing in popularity, especially as sequencing costs fall and genomics becomes more accessible. So it's not surprising that the DIY clinical trial is gaining ground as well. An investment advisor in Silicon Valley launched her own clinical trial on the type of vitamin B she, and others with her genotype, should take.
    Full story

  • Price Wars for Cancer Drugs

    Apr 2, 2012, 03:25 AM by Michael Croft
    Reuters | Part of the drug discovery challenge is price and the "pricing crisis" is reaching new heights in terms of cancer medicines. Many patients don't have access to drugs that could help because of price limitations. 
    Full story

  • Courtagen Releases Genetic Tests for Mitochondrial Disease

    Mar 30, 2012, 03:30 AM by Michael Croft
    Mass High Tech | Courtagen, a private genomics and proteomics company based in Woburn, Mass., has announced its first genetic test to diagnose mitochondiral disease. The company says it plans to expand test options later this year and ultimately offer a combination of multiplex proteomic and next-generation sequencing genomic assays using Illumina’s MiSeq and HiSeq platforms.
    Full story

  • Roche Again Raises Illumina Bid

    Mar 30, 2012, 02:30 AM by Michael Croft
    New York Times | Roche raised its bid for Illumina yesterday, offering $51 per share, valuing the company at more than $6 billion. 
    Full story

  • Paul Allen Pledges Another $300m to Institute for Brain Science

    Mar 30, 2012, 02:20 AM by Michael Croft
    Seattle Times | Paul Allen, co-founder of Microsoft and founder of the Allen Institute for Brain Sciences, has committed an additional $300 million toward the Institute's 10-year plan.
    Full story

  • Dada Scale Data

    Mar 30, 2012, 01:30 AM by Michael Croft
    Nature News | The US Office of Science and Technology Policy unveiled a $200 million initiative yesterday to manage data at the databytes leves--that's 1021 bytes.
    Full story

  • Amazon to Store, Share All of 1000 Genomes Project

    Mar 29, 2012, 09:45 AM by Michael Croft
     New York Times | Amazon Web Services will store and make available the entire contents of the 1000 Genomes project--some 200 terabytes. 
    Full story

  • March News Briefs

    Mar 29, 2012, 07:20 AM by Michael Croft
    Bio-IT World | March news briefs from IO Informatics, Biomatters, BGI, DNA Electronics, and Thomson Reuters.
    Full story

  • IOM Releases Guidelines for Genomics Research

    Mar 29, 2012, 07:15 AM by Michael Croft
    The Chronicle | The Institute of Medicine of the National Academies released a report last week to estabish standards for genomics research and other develping medical sciences with large datasets and a framework for monitoring and ensuring translational research integrity. 
    Full story

  • The Y Chromosome Is Safe

    Mar 28, 2012, 06:35 AM by Michael Croft
    The Atlantic | The Y chromosome is safe, says a new Nature study. The idea that the Y chromosome was quickly losing genes, the "rotting Y" theory, is stalled according to research from geneticists at the Whitehead Institute for Biomedical Research.
    Full story

  • Biotech Business Model Menu

    Mar 28, 2012, 06:00 AM by Michael Croft
    Forbes | Biotech business models can make a difference in funding and success, but it's not a one-size-fits-all approach. 
    Full story

  • Jiff Launches First HIPAA-Compliant Health Care Social Network

    Mar 27, 2012, 05:10 AM by Michael Croft
    Bio-IT World | Jiff Inc. unveiled the first HIPAA-compliant health care social network and digital health apps platform: Circle of Health earlier this month. Circle of Health will allow consumers, their loved ones, and their care providers to share critical health information and easily monitor and manage their health through digital health applications that seamlessly integrate with each other. 
    Full story

  • Supreme Court Calls for Review of Gene Patent Case

    Mar 27, 2012, 00:10 AM by Michael Croft
    New York Times | The US Supreme Court ordered an appeals court to reconsider its decision upholding two Myriad Genetics gene patents in light of last week's ruling on a diagnostic test.
    Full story

  • Columbia University Sues Illumina Over NGS Patents

    Mar 27, 2012, 00:05 AM by Michael Croft
    Reuters | Columbia University filed suit against Illumina yesterday for allegedly infringing on five DNA sequencing patents. The patents were assigned between 2009 and 2012 and list several inventors.
    Full story

  • March New Products

    Mar 26, 2012, 06:25 AM by Michael Croft
    Bio-IT World | New products in clinical trials, sequencing analysis, storage, chromatography and more from across the industry. 
    Full story

  • Another Look at the MinION

    Mar 26, 2012, 05:35 AM by Michael Croft
    Wired | Wired looks at Oxford Nanopore's USB sequencer, the MinION. It has the potential to be a game changer, but users are still waiting to see it in action.
    Full story

  • A Preview of Bio-IT World Expo 2012

    Mar 26, 2012, 00:35 AM by Michael Croft
    Bio-IT World | On April 24-26, Bio-IT World will host its tenth anniversary conference in Boston, and anticipates the largest gathering to date, along with a record 125 companies exhibiting this year. More than 200 speakers will present in a total of 12 concurrent conference tracks, as well as 15 short courses, not to mention the 2012 Bio-IT World Best Practices Awards and the Best of Show exhibit prizes. Here are just a few of the potential highlights on this year’s program. 
    Full story

  • Growth at San Diego Supercomputing Center

    Mar 23, 2012, 05:00 AM by Michael Croft
    Lab Manager | The San Diego Supercomputer Center has been growing over the past three years, and has created a fully integrated "big data" environment.
    Full story